These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1800220)

  • 1. [Captopril reduction of albuminuria in type-II diabetics with diabetic nephropathy].
    Melchor-Ortiz JL; Wacher-Rodarte N; Halabe-Cherem J; Lifshitz-Guinzberg A
    Gac Med Mex; 1991; 127(3):261-6. PubMed ID: 1800220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP; Raskovic M; Schimke E
    Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
    Hirata-Dulas CA; Rith-Najarian SJ; McIntyre MC; Ross C; Dahl DC; Keane WF; Kasiske BL
    Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure by 24 h ambulatory recordings in type 2 (non-insulin dependent) diabetics. Relationship to urinary albumin excretion.
    Schmitz A; Pedersen MM; Hansen KW
    Diabete Metab; 1991; 17(2):301-7. PubMed ID: 1864438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
    Fernández R; Puig JG; Rodríguez-Pérez JC; Garrido J; Redon J;
    J Hum Hypertens; 2001 Dec; 15(12):849-56. PubMed ID: 11773987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K; Ikarashi T
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
    Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
    Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy.
    Kimura S; Inoguchi T; Yokomizo H; Maeda Y; Sonoda N; Takayanagi R
    Diabetes Obes Metab; 2012 Jul; 14(7):666-9. PubMed ID: 22268518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R; Salinas I; Teixidó J; Lucas A; Felip A; Sanmarti A
    J Hum Hypertens; 1990 Dec; 4(6):671-5. PubMed ID: 2096209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T; Khanna A; Kimball K; Wesson DE
    Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effect of N-type Ca channel blockade in diabetic nephropathy.
    Fujisawa T; Ikegami H; Noso S; Hiromine Y; Kawabata Y; Nishino M; Asano K; Ogihara T
    J Diabetes Complications; 2007; 21(4):252-7. PubMed ID: 17616356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Circulation; 2004 Aug; 110(8):921-7. PubMed ID: 15302780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea.
    Kim DM; Ahn CW; Park JS; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S169-72. PubMed ID: 15563971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.